CIAM
ITOS

Caitong International Asset Management’s iTeos Therapeutics ITOS Stock Holding History

Caitong International Asset Management’s Portfolio ITOS Stock Details ITOS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q3 		– Sell
-1,073
Closed -$10.7K – 2227
2025
Q2 		$10.7K Buy
1,073
+579
+117% +$4.66K 0.01% 698
2025
Q1 		$2.95K Buy
+494
New +$3.63K ﹤0.01% 1200

Other funds holding ITOS

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

Caitong International Asset Management's ITOS Position: Q3 2025 in Review

Caitong International Asset Management sold out of iTeos Therapeutics (ITOS) in Q3 2025, closing a stake of 1,073 shares — an estimated $10.7K sold.

Caitong International Asset Management first reported a position in ITOS in Q1 2025 and held it in 2 quarters. The position peaked at $10.7K in Q2 2025. 1 fund tracked by Wall St. Rank holds ITOS as of Q3 2025.

  • Caitong International Asset Management reported no remaining iTeos Therapeutics position as of Q3 2025 after selling out during the quarter.
  • Caitong International Asset Management sold 1,073 iTeos Therapeutics shares in Q3 2025, an estimated $10.7K.
  • Caitong International Asset Management first reported a position in iTeos Therapeutics in Q1 2025 and held it in 2 quarters.
  • Caitong International Asset Management's iTeos Therapeutics position peaked at $10.7K in Q2 2025.
  • 1 fund tracked by Wall St. Rank held iTeos Therapeutics as of Q3 2025.

Based on Caitong International Asset Management's 13F filing for Q3 2025, filed 19 Nov 2025.